Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis

• Glavni autori: Elizabeth R. Packnett (Autor), Nicole M. Zimmerman (Autor), Patricia Novy (Autor), Laura C. Morgan (Autor), Nnenna Chime (Autor), Parinaz Ghaswalla (Autor)
• Format: Knjiga
• Izdano: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

In the United States (US), meningococcal serogroup B (MenB) vaccination has been recommended for 16-23-year-olds (preferably 16-18 years) based on shared clinical decision-making since 2015. MenB vaccine coverage (≥1 dose) by age 17 years has been reported, but initiation at older ages and by insura...